HCW Biologics Inc. Common Stock (HCWB) is a publicly traded Healthcare sector company. As of October 24, 2026, HCWB trades at $1.12 with a market cap of $2.50M and a P/E ratio of -0.13. HCWB moved +0.00% today. Year to date, HCWB is -82.43%; over the trailing twelve months it is -95.00%. Its 52-week range spans $1.09 to $106.80. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces HCWB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for HCWB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $1.12 |
| Market Cap | $2.50M |
| P/E Ratio | -0.13 |
| EPS | $-12.52 |
| Dividend Yield | 0.00% |
| 52-Week High | $106.80 |
| 52-Week Low | $1.09 |
| Volume | 76.91K |
| Avg Volume | 0 |
| Revenue (TTM) | $6.66M |
| Net Income | $-5.58M |
| Gross Margin | 96.73% |
1 analysts cover HCWB: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.